J&J reported $56.35B in Current Assets for its fiscal quarter ending in September of 2026.





Current Assets Change Date
AbbVie USD 37.48B 3.81B Sep/2026
Abbott USD 23.5B 1.02B Sep/2026
Amgen USD 34.36B 598M Sep/2026
AstraZeneca USD 31.45B 3.48B Sep/2026
Baxter International USD 6.83B 163M Sep/2026
Bayer EUR 39.6B 5.96B Sep/2026
Becton, Dickinson and Co. USD 8.32B 178M Sep/2026
Biogen USD 7.58B 278.7M Sep/2026
Boston Scientific USD 8.16B 192M Sep/2026
Bristol-Myers Squibb USD 29.77B 1.19B Sep/2026
CONMED USD 682.04M 6.37M Sep/2026
Cooper Companies USD 2.28B 18.3M Jun/2026
Dexcom USD 3.92B 170.6M Sep/2026
Edwards Lifesciences USD 7.25B 428.6M Sep/2026
Eli Lilly USD 65.26B 591M Sep/2026
Gilead Sciences USD 16.55B 4.02B Sep/2026
GlaxoSmithKline GBP 17.9B 336M Sep/2026
Globus Medical USD 2.18B 33.55M Sep/2026
Insulet USD 2.04B 192.4M Sep/2026
Integra LifeSciences USD 1.19B 1.54M Sep/2026
Intuitive Surgical USD 10.65B 1.68B Sep/2026
J&J USD 56.35B 3.42B Sep/2026
Medtronic USD 24.39B 397M Jun/2026
Merck USD 38.94B 2.26B Sep/2026
Merit Medical Systems USD 1.2B 86.58M Sep/2026
Novartis USD 28.75B 1.4B Sep/2026
Pfizer USD 45.01B 3.65B Sep/2026
Regeneron Pharmaceuticals USD 20.8B 2.35B Sep/2026
Roche Holding CHF 35.44B 3.29B Jun/2026
Sanofi EUR 33.21B 1.68B Sep/2026
Stryker USD 14.18B 235M Sep/2026
Tandem Diabetes Care USD 820.72M 16.08M Sep/2026
Teva Pharmaceutical Industries USD 14.6B 842M Sep/2026
Vertex Pharmaceuticals USD 11.69B 857.4M Sep/2026
Zimmer Biomet Holdings USD 5.13B 32.3M Sep/2026
Zoetis USD 6.29B 63M Sep/2026